Paul Fawcett, PhD

Center Director/Principal Research Scientist

Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

Biography

B.S. biology , M.S. Biology , Ph.D. Chemistry/Biochemistry ( U Mass Lowell ) . Research on inflammatory and infectious diseases . Lyme , H.p . and JRA . Clinical assay development and use . Name and Position Title Paul T. Fawcett, Ph.D. Director Center for Clinical Diagnostics Education Institution and Location Degree Year(s) Field of Study University of Lowell B.S. 06/1977 Biology University of Massachusetts Lowell M.S. 06/1982 Biology University of Massachusetts Lowell Ph.D. 06/1986 Biochemistry/Chemistry Employment Principal Research Scientist Alfred I. duPont Hospital for Children, Wilmington, DE Director, Center for Clinical Diagnostics Head, Immunology Laboratories Head, Transplant Diagnostic Laboratory Director, Life Science Center Chair, Institutional Animal Care and Use Committee Selected Publications 1. Brescia AC, Rose CD, McCahan SM, Stetson T, Fawcett PT. “Differential gene expression profiles between fibroblast-like synoviocytes (FLS) from chronic and acute Lyme arthritis in the pediatric population,†American College of Rheumatology 70th Annual Scientific Meeting, Washington DC, November, 2006. Arthritis Rheum 54:S696, 2006. 2. Fawcett PT, Brescia AC, Cattalini M, Maduskuie VL, Rose CD. “Proteomic profile of synovial fluid of JIA patients with divergent outcomes after joint injection,†American College of Rheumatology 70th Annual Scientific Meeting, Washington DC, November, 2006. Arthritis Rheum 54:S168,2006. 3. Fawcett PT, Rose CD, Maduskuie VL, Stetson T, Brescia AC, Stella MK, Stanek PA. “In-Vitro production of inflammatory mediators by fibroblast-like stem cells from the synovial fluid of pediatric Lyme arthritis patients,†American College of Rheumatology 70th Annual Scientific Meeting, Washington DC, November, 2006. Arthritis Rheum 54:S168,2006. 4. Catalini M, Maduskuie V, Fawcett PT, Brescia AC, Rose CD. “Predicting duration of effect of joint injection among children with knee arthritis using cytokine profile in synovial fluid (sf) at injection time,†American College of Rheumatology 70th Annual Scientific Meeting, Washington DC, November, 2006. Arthritis Rheum 54:S326,2006. 5. Fawcett PT, Rose CD, Maduskuie VL, Brescia AC. “Comparison of inflammatory mediator profiles in synovial fluid from pediatric patients with acute and chronic Lyme arthritis.†American College of Rheumatology 71th Annual Scientific Meeting, Boston MA, November, 2007. Arthritis Rheum 56:S141,2007. 6. Brescia AC, Rose CD, McCahan SM, Stetson T, Fawcett, PT, “Gene expression profiles in an expanded cohort of pediatric Lyme arthritis. American College of Rheumatology 71st Annual Scientific Meeting, Boston, MA, November, 2007. Arthritis Rheum 56:S142, 2007. 7. Fawcett PT, Rose CD, Brescia AC, Maduskuie VL, Postell MM, Stetson T, Stanek PA. “Determination of in-vivo and in-vitro production of inflammatory mediators in pediatric patients with acute and chronic Lyme arthritis. American College of Rheumatology 71st Annual Scientific Meeting, Boston MA, November, 2007. Arthritis Rheum 56:S373, 2007. 8. Taddio A, Montico M, Fawcett PT, Maduskuie VL, Cattalini M, Ronfani L, Brescia AC, Rose CD. “Cytokine profile in synovial fluid (SF) as major duration predictor of intra-articular corticosteroid (IAC) injection in juvenile arthritis.†(podium presentation) American College of Rheumatology 71st Annual Scientific Meeting, Boston MA, November, 2007. Arthritis Rheum 56:S829, 2007. 9. AC Brescia, SM McCahan, T Stetson, CD Rose, PT Fawcett “Unique expression of bone morphogenetic protein 4 in fibroblast-like synoviocytes from children with oligoarticular JIA,†Keystone Pediatric Rheumatology Symposium, Keystone, CO, March, 2008 (podium), Pediatric Academic Societies’ Annual meeting, Honolulu, HI, May, 2008. 10. AC Brescia, SM McCahan, T Stetson, CD Rose, PT Fawcett, “Fibroblast Transformation May Have a Role in Perpetuation of Synovitis in Antibiotic-Resistant Pediatric Lyme Arthritis†Keystone Pediatric Rheumatology Symposium, Keystone, CO, March 2008, Pediatric Academic Societies’ Annual meeting, Honolulu, HI, May 2008 (podium). 11. M Catalini, V Maduskuie, PT Fawcett, AC Brescia, CD Rose, “Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection,†Clin. Exp Rheumatology 26(6):1153-60, 2008. 12. AC Brescia, CD Rose, PT Fawcett, “Prolonged Synovitis in Pediatric Lyme Arthritis cannot be predicted by clinical or laboratory parameters,†Clinical Rheumatology 28 (5):591-593, 2009.

  • Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia; JBMR Plus; (2023).

    View Full Publication
  • Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate; Pediatrics; (2019).

    View Full Publication
  • Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress; Inflammation; (2018).

    View Full Publication
  • The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: Dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy; Arthritis and Rheumatology; (2014).

    View Full Publication
  • Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo; BMC Cancer; (2011).

    View Full Publication
  • Prolonged synovitis in pediatric lyme arthritis cannot be predicted by clinical or laboratory parameters; Clinical Rheumatology; (2009).

    View Full Publication
  • Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection; Clinical and Experimental Rheumatology; (2008).

    View Full Publication
  • Cytokine load in prestorage leukoreduced PRBC transfusions in premature infants; Journal of Perinatology; (2005).

    View Full Publication
  • Long-term effects of immunization with recombinant lipoprotein outer surface protein A on serologic test for Lyme disease; Clinical and Diagnostic Laboratory Immunology; (2004).

    View Full Publication
  • Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients; BMC Microbiology; (2004).

    View Full Publication
  • C<inf>6</inf> Test as an Indicator of Therapy Outcome for Patients with Localized or Disseminated Lyme Borreliosis; Journal of Clinical Microbiology; (2003).

    View Full Publication
  • Growth of Helicobacter pylori in a long spiral form does not alterexpression of immunodominant proteins; BMC Microbiology; (2002).

    View Full Publication
  • In vitro assessment of antiborrelial activity of OspA vaccine sera; Clinical and Diagnostic Laboratory Immunology; (2002).

    View Full Publication
  • Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (2001).

    View Full Publication
  • Arthritis following recombinant outer surface protein A vaccination for lyme disease; Journal of Rheumatology; (2001).

    View Full Publication
  • Antibody response to IR<inf>6</inf>, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans; Journal of Infectious Diseases; (2001).

    View Full Publication
  • Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii; Journal of Clinical Microbiology; (1999).

    View Full Publication
  • Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis; Journal of Rheumatology; (1999).

    View Full Publication
  • Comparison of immunodot and Western blot assays for diagnosing Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (1998).

    View Full Publication
  • Correlation of seroreactivity with response to antibiotics in pediatric Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (1997).

    View Full Publication
  • Residual serologic reactivity in children with resolved Lyme arthritis; Journal of Rheumatology; (1996).

    View Full Publication
  • Usefulness of soluble interleukin-2 receptor specificity [9]; Journal of Pediatrics; (1996).

    View Full Publication
  • Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis; Journal of Rheumatology; (1995).

    View Full Publication
  • Soluble interleukin-2 receptor as a predictor of neonatal sepsis; The Journal of Pediatrics; (1995).

    View Full Publication
  • Pharmacokinetics of teratogenic antibodies administered to rats; Teratology; (1995).

    View Full Publication
  • Pediatric Lyme Arthritis: Clinical Spectrum And Outcome; Journal of Pediatric Orthopaedics; (1994).

    View Full Publication
  • Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate; Annals of the Rheumatic Diseases; (1994).

    View Full Publication
  • The Overdiagnosis of Lyme Disease in Children Residing in an Endemic Area; Clinical Pediatrics; (1994).

    View Full Publication
  • Reinfection in paediatric Lyme borreliosis [2]; Annals of the Rheumatic Diseases; (1993).

    View Full Publication
  • Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease; Journal of Pediatric Gastroenterology and Nutrition; (1993).

    View Full Publication
  • Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting; Journal of Rheumatology; (1993).

    View Full Publication
  • Serial measurement of soluble interleukin 2 receptor levels: An early indicator of treatment response for Lyme disease; Journal of Rheumatology; (1993).

    View Full Publication
  • Soluble interleukin‐2 receptor levels in infants with bronchopulmonary dysplasia; Pediatric Pulmonology; (1992).

    View Full Publication
  • Lyme neuroborreliosis: A potential cause of median neuropathy in a child and young adult; Infectious Diseases in Clinical Practice; (1992).

    View Full Publication
  • Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens; Journal of Rheumatology; (1992).

    View Full Publication
  • Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease; Journal of Rheumatology; (1991).

    View Full Publication
  • Use of Western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease; Pediatrics; (1991).

    View Full Publication
  • Induction of humoral manifestations of autoimmunity following intraperitoneal injection of complete freund's adjuvant in mice; Autoimmunity; (1990).

    View Full Publication
  • Suppression of malaria-induced autoimmunity by immunization with cryoglobulins; Cellular Immunology; (1989).

    View Full Publication
  • GLOVE POWDER AND HIV ELISA TESTS; The Lancet; (1989).

    View Full Publication
  • An adsorption procedure to increase the specificity of enzyme‐linked immunosorbent assays for lyme disease without decreasing sensitivity; Arthritis &amp; Rheumatism; (1989).

    View Full Publication
  • Androgen Suppression of Circulating Immune Complexes and Enhanced Survival in Murine Malaria; Proceedings of the Society for Experimental Biology and Medicine; (1982).

    View Full Publication